| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Artiva Biotherapeutics, Inc. (ARTV) has 14 insiders with recent SEC Form 4 filings, including 8 buys and 1 sell. ARTV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 16.23M | $163.13M | +1.03M | |
| CEO | 1.54M | $15.43M | - | |
| COO | 337.9K | $3.40M | - | |
| Other | 293.4K | $2.95M | - | |
| VP | 148.2K | $1.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Aslan Fred | President And CEO | Sell | 25,500 | $2.73 | $69,579.30 | -6.2% | +23.3% | - | |
| Jul 22, 2024 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 8,333,333 | $12.00 | $99,999,996.00 | +702.0% | -11.0% | -78.1% | |
| Jul 22, 2024 | Gc Corp. | 10% Owner | Buy | 2,083,332 | $12.00 | $24,999,984.00 | +83.9% | -11.0% | -78.1% | |
| Jul 22, 2024 | Huh Yong-Jun | Director | Buy | 2,083,332 | $12.00 | $24,999,984.00 | +83.9% | -11.0% | -78.1% | |
| Jul 22, 2024 | 5am Partners Vi, LLC | 10% Owner | Buy | 833,333 | $12.00 | $9,999,996.00 | +239.0% | -11.0% | -78.1% | |
| Jul 22, 2024 | Venbio Global Strategic Fund Iii, L.P. | - | Buy | 416,666 | $12.00 | $4,999,992.00 | +27.4% | -11.0% | -78.1% |